Literature DB >> 26954846

Long-Term Survival Rates of Patients Undergoing Vitrectomy for Proliferative Diabetic Retinopathy.

Philip J Banerjee1, Rene Moya1,2, Catey Bunce1, David G Charteris1, David Yorston1,3, Louisa Wickham1.   

Abstract

PURPOSE: Reported 5-year survival rates in patients undergoing vitreous surgery for proliferative diabetic retinopathy (PDR) range from 68-95%. Studies relating survival rates to medical baseline characteristics predate the millennium. This study aimed to update data on life expectancy of patients undergoing vitrectomy for PDR and identify baseline factors which may influence survival.
METHODS: A retrospective cohort study of consecutive patients who underwent their first pars-plana vitrectomy for PDR between April 2004 and May 2005 was performed. Survival status on 1 May 2012 was the primary endpoint. The Kaplan-Meier life table method was used to determine survival rates. Univariate and multiple variable Cox proportional hazards regressions were used to identify risk factors for mortality.
RESULTS: A total of 148 patients were included in the study, with a mean age of 54 years (range 20-80 years) at time of surgery. The 3-, 5- and 7-year survival rates were 94%, 86% and 77%, respectively (95% confidence interval, CI, 88-97%, 79-91% and 68-84%, respectively). Renal failure was the most common cause of death. The presence of limb ulcers at baseline was the most important prognostic indicator for mortality, with a hazard ratio of 3.13 (95% CI 1.46-6.71, p = 0.003) and a survival rate at 5 years reduced to 79%.
CONCLUSION: The 5-year survival rate remains comparable to those reported 20 years ago despite a lowering in threshold for vitrectomy and increased health awareness. Limb ulcers are strongly associated with increasing mortality. Clinicians should remain mindful of the systemic associations of diabetes particularly in advanced retinal disease.

Entities:  

Keywords:  Diabetes; proliferative diabetic retinopathy; survival; vitrectomy; vitreous

Mesh:

Year:  2016        PMID: 26954846     DOI: 10.3109/09286586.2015.1089578

Source DB:  PubMed          Journal:  Ophthalmic Epidemiol        ISSN: 0928-6586            Impact factor:   1.648


  7 in total

1.  Ocular findings, surgery details and outcomes in proliferative diabetic retinopathy patients with chronic kidney disease.

Authors:  Jipeng Li; Aman Chandra; Lin Liu; Lin Zhang; Jun Xu; Meng Zhao
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

2.  Evaluation of Retinal Detachment After Diabetic Vitrectomy: Causes and Ways of Management.

Authors:  Ahmed M Abdelhadi; Hany Ahmed Helaly; Amr Abuelkeir
Journal:  Clin Ophthalmol       Date:  2020-01-09

3.  Long-term outcomes of vitrectomy for proliferative diabetic retinopathy.

Authors:  Vivian Schreur; Jody Brouwers; Ramon A C Van Huet; Sandra Smeets; Milan Phan; Carel B Hoyng; Eiko K de Jong; B Jeroen Klevering
Journal:  Acta Ophthalmol       Date:  2020-07-09       Impact factor: 3.761

4.  Vitrectomy and All-Cause and Cause-Specific Mortality in Elderly Patients With Vitreoretinal Diseases: A Nationwide Cohort Study.

Authors:  Yoon Jeon Kim; Ji Sung Lee; Yunhan Lee; Hun Lee; Jae Yong Kim; Hungwon Tchah
Journal:  Front Med (Lausanne)       Date:  2022-04-25

5.  Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease.

Authors:  Abdah Khairiah Che Md Noor; Evelyn Li Min Tai; Yee Cheng Kueh; Ab Hamid Siti-Azrin; Zamri Noordin; Ismail Shatriah
Journal:  Int J Environ Res Public Health       Date:  2020-01-02       Impact factor: 3.390

6.  Diabetic retinopathy predicts cardiovascular mortality in diabetes: a meta-analysis.

Authors:  Xiao-Hong Xu; Bo Sun; Shan Zhong; Dong-Dong Wei; Ze Hong; Ai-Qiang Dong
Journal:  BMC Cardiovasc Disord       Date:  2020-11-04       Impact factor: 2.298

7.  Relationship between renal function and prognosis of Chinese proliferative diabetic retinopathy patients undergoing the first vitrectomy: protocol for a prospective cohort study.

Authors:  Chunyan Lei; Keren Zhang; Tiancong Chang; Qibo Ran; Meixia Zhang
Journal:  BMJ Open       Date:  2021-12-06       Impact factor: 2.692

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.